Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant.
Prockop SE, Hasan A, Doubrovina E, Dahi PB, Rodriguez-Sanchez I, Curry M, Mauguen A, Papanicolaou GA, Su Y, Yao J, Arcila M, Boulad F, Castro-Malaspina H, Cho C, Curran KJ, Giralt S, Kernan NA, Koehne G, Jakubowski A, Papadopoulos E, Perales MA, Politikos I, Price K, Selvakumar A, Sauter CS, Tamari R, Vizconde T, Young JW, O'Reilly RJ.
Prockop SE, et al. Among authors: selvakumar a.
J Clin Invest. 2023 May 15;133(10):e165476. doi: 10.1172/JCI165476.
J Clin Invest. 2023.
PMID: 36951958
Free PMC article.